1. Home
  2. CNTX vs ESP Comparison

CNTX vs ESP Comparison

Compare CNTX & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • ESP
  • Stock Information
  • Founded
  • CNTX 2015
  • ESP 1928
  • Country
  • CNTX United States
  • ESP United States
  • Employees
  • CNTX N/A
  • ESP N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • ESP Industrial Machinery/Components
  • Sector
  • CNTX Health Care
  • ESP Technology
  • Exchange
  • CNTX Nasdaq
  • ESP Nasdaq
  • Market Cap
  • CNTX 78.0M
  • ESP 84.1M
  • IPO Year
  • CNTX 2021
  • ESP N/A
  • Fundamental
  • Price
  • CNTX $0.61
  • ESP $36.59
  • Analyst Decision
  • CNTX Strong Buy
  • ESP
  • Analyst Count
  • CNTX 4
  • ESP 0
  • Target Price
  • CNTX $6.00
  • ESP N/A
  • AVG Volume (30 Days)
  • CNTX 164.6K
  • ESP 26.2K
  • Earning Date
  • CNTX 05-07-2025
  • ESP 05-12-2025
  • Dividend Yield
  • CNTX N/A
  • ESP 2.73%
  • EPS Growth
  • CNTX N/A
  • ESP 39.20
  • EPS
  • CNTX N/A
  • ESP 2.67
  • Revenue
  • CNTX N/A
  • ESP $45,965,588.00
  • Revenue This Year
  • CNTX N/A
  • ESP N/A
  • Revenue Next Year
  • CNTX N/A
  • ESP N/A
  • P/E Ratio
  • CNTX N/A
  • ESP $13.69
  • Revenue Growth
  • CNTX N/A
  • ESP 29.60
  • 52 Week Low
  • CNTX $0.49
  • ESP $20.20
  • 52 Week High
  • CNTX $2.75
  • ESP $39.41
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 33.91
  • ESP 63.52
  • Support Level
  • CNTX $0.49
  • ESP $34.90
  • Resistance Level
  • CNTX $0.71
  • ESP $39.41
  • Average True Range (ATR)
  • CNTX 0.08
  • ESP 1.41
  • MACD
  • CNTX -0.02
  • ESP -0.04
  • Stochastic Oscillator
  • CNTX 33.31
  • ESP 64.29

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About ESP Espey Mfg. & Electronics Corp.

Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.

Share on Social Networks: